New Providence, NJ, United States of America

Song Xiao Huang

This inventor holds 3 USPTO granted patents. Top assignees: Ptc Therapeutics, Inc., F. Hoffmann-La Roche Ag. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Song Xiao Huang. Retrieved from https://idiyas.com/inventor/song-xiao-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 20.7

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • New Providence, NJ (US) (2014)
  • San Leandro, NJ (US) (2017)
  • San Leandro, CA (US) (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Song Xiao Huang

Introduction: Song Xiao Huang is a prolific inventor based in New Providence, NJ, known for his groundbreaking contributions to various technological fields.

Latest Patents: Song Xiao Huang holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in research and development, Song Xiao Huang has worked for leading tech companies, where he spearheaded innovative projects that have received international recognition.

Collaborations: Throughout his career, Song Xiao Huang has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions, fostering a culture of innovation and knowledge sharing.

Conclusion: Song Xiao Huang's passion for pushing the boundaries of technology and his relentless pursuit of excellence continue to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…